Drug Type Gene therapy |
Synonyms AAV-BDNF, BDNF MC4R |
Target |
Action modulators |
Mechanism BDNF modulators(Brain-derived neurotrophic factor modulators), MC4R modulators(Melanocortin receptor 4 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | United States | 09 Jun 2024 |